Similar articles

• [CA 19-9 and cancer of the pancreas. Critical review of the literature].

  Delcourt A. Delcourt A. Acta Gastroenterol Belg. 1987 Jan-Feb;50(1):1-8. Acta Gastroenterol Belg. 1987. PMID: 3321822 Review. French. No abstract available.
• [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].

  Röthlin M, Metzger U, Joller H, Largiadèr F. Röthlin M, et al. Schweiz Med Wochenschr. 1988 Jun 18;118(24):924-9. Schweiz Med Wochenschr. 1988. PMID: 2456610 German.
• CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.

  Paganuzzi M, Onetto M, Marroni P, Barone D, Conio M, Aste H, Pugliese V. Paganuzzi M, et al. Cancer. 1988 May 15;61(10):2100-8. doi: 10.1002/1097-0142(19880515)61:10<2100::aid-cncr2820611028>3.0.co;2-z. Cancer. 1988. PMID: 2834038
• [Attention to CA 19.9 in alcoholics. Apropos of a case].

  Giovannini M, Penalvert F, Maillot A, Escoffier JM, Botta D, Gauthier A. Giovannini M, et al. Ann Gastroenterol Hepatol (Paris). 1987 Dec;23(7):393. Ann Gastroenterol Hepatol (Paris). 1987. PMID: 3481241 French. No abstract available.
• Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.

  Boyd EJ, Rinderknecht H, Wormsley KG. Boyd EJ, et al. Int J Pancreatol. 1988 May;3(4):229-40. doi: 10.1007/BF02788452. Int J Pancreatol. 1988. PMID: 3290345 Review. No abstract available.